# Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4

> **NCT00910130** · — · UNKNOWN · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 30 (estimated)

## Conditions studied

- Insulin Resistance
- Diabetes
- End Stage Renal Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00910130
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00910130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00910130, "Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00910130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*